Meeting
2023 ASCO Annual Meeting
Impact of early testing and analysis of germline genetic mutation patterns in patients with breast cancer: A single institution experience.
Authors
Aswanth Reddy
Mercy Clinic Oncology, Fort Smith, AR
Aswanth Reddy , Nkolika Nwankwo , Kathleen Milam
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10613)
DOI
10.1200/JCO.2023.41.16_suppl.10613
Abstract #
10613
Poster Bd #
246
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Women with pathogenic variants in moderate penetrance breast cancer genes: How frequently do they meet high penetrance genetic testing criteria?
First Author: Nicole Casasanta
Poster
2020 Genitourinary Cancers Symposium
Prevalence of pathogenic germline risk variants (PVs) in 1829 renal cell carcinoma (RCC) patients (pts).
First Author: Sarah Abou Alaiwi
Poster
2017 ASCO Annual Meeting
Expanded yield of multiplex panel testing in fully accrued prospective trial.
First Author: Gregory Idos
Poster
2016 ASCO Annual Meeting
Risk of HER2-positive breast cancer among germline CHEK2 mutation carriers with breast cancer.
First Author: Chethan Ramamurthy